The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: A community study from rural Bangladesh

International Journal of Epidemiology

Volumn 32, Issue 1, 2003, Pages 106-115

  Aaby, Peter ^a   Bhuiya, Abbas ^b   Nahar, Lutfun ^b   Knudsen, Kim ^a   de Francisco, Andres ^b   Strong, Michael ^b  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Measles; Measles immunization; Non specific effects of vaccination; Post measles mortality

Indexed keywords

BCG VACCINE; MEASLES VACCINE;

CHILD HEALTH; CHILD MORTALITY; IMMUNIZATION; MEASLES;

ARTICLE; BANGLADESH; CALCULATION; CHILD; CHILDHOOD MORTALITY; COMMUNITY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MEDICAL RESEARCH; PRIORITY JOURNAL; RURAL AREA; STATISTICAL ANALYSIS; SURVIVAL;

BANGLADESH; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; DIARRHEA; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT MORTALITY; MALE; MEASLES; MEASLES VACCINE; RURAL POPULATION; SURVIVAL;

BANGLADESH;

EID: 0242432490     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyg005     Document Type: Article

References (37)

1. Aaby P, Clements J, Orinda V. Mortality from Measles: Measuring the Impact. Geneva: Expanded Programme on Immunization, World Health Organization, 1991.
2. Dave KH. Measles in India. Rev Infect Dis 1983;5:406-10.
3. Koster FT, Curlin GC, Aziz KMA, Haque A. Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull World Health Organ 1981;59:901-08.
4. Bhuiya A, Wojtyniak B, D'Souza S, Nahar L, Shaikh K. Measles case fatality among under-fives: a multivariate analysis of risk factors in a rural area of Bangladesh. Soc Sci Med 1987;24:439-43.
5. Fauveau V, Chakraborty J, Sarder AM, Khan MA, Koenig MA. Measles under-9-month-old in rural Bangladesh: its significance for age at immunization. Bull World Health Organ 1991;69:67-72.
6. Clemens JD, Stanton BF, Chakraborty J et al. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 1988;128: 1330-39.
7. Koenig MA, Khan MA, Wojtyniak B et al. The impact of measles vaccination upon childhood mortality in Matlab, Bangladesh. Bull World Health Organ 1990;68:441-47.
8. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984;8:13-21.
9. Aaby P, Pedersen IR, Knudsen K et al. Child mortality related to seroconversion or lack of seroconversion after measles vaccination. Pediatr Infect Dis J 1989;8:197-200.
10. Aaby P, Knudsen K, Jensen TG et al. Measles incidence, vaccine efficacy and mortality in two urban African areas with high vaccination coverage. J Infect Dis 1990;162:1043-48.
11. Garenne M, Cantrelle P. Rougeole et mortalité au Senegal: ensi de l'impact de la vaccination effectué a Khombole 1965-1968 sur la survie des enfants. In: P Cantrelle, S Dormont, P Farques, J Goujard, J Guignard, C Rumeau-Rouquette (eds). Estimation de la Mortalité du Jeune Enfant (0-5 ans) pour Guider les Actions de Santé dans les Pays en Developpement. Paris: INSERM, 1986, pp. 515-32.
12. Aaby P, Samb B, Simondon F et al. Divergent mortality for male and female recipients of low-titre and high-titre measles vaccines in rural Senegal. Am J Epidemiol 1993;138:746-55.
13. Velema JP, Alihonou EM, Gandaho T, Hounye FH. Childhood mortality among users and non-users of primary health care in a rural West African community. Int J Epidemiol 1991;20:474-79.
14. The Kasongo Project Team. Influence of measles vaccination on survival pattern of 7-35-month-old children in Kasongo, Zaire. Lancet 1981;i:764-67.
15. Hartfield J, Morley D. Efficacy of measles vaccine. Journal of Hygiene (Cambridge) 1963;61:143-47.
16. Chen RT, Weierbach R, Bisoffi Z et al. A 'Post-honeymoon period' measles outbreak in Muyinga Sector, Burundi. Int J Epidemiol 1994; 23:185-93.
17. Holt EA, Boulos R, Halsey NA, Boulos IM, Boulos C. Childhood survival in Haiti: Protective effect of measles vaccination. Pediatrics 1990;85:188-94.
18. Aaby P, Samb B, Simondon F, Coll Seck AM, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunization: analysis of mortality studies from developing countries. BMJ 1995;311:481-85.
19. Hull HF, Williams PJ, Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet 1983;i:972-75.
20. Aaby P, Lisse I, Mølbak K, Knudsen K, Whittle H. No persistent T lymphocyte immunosuppression or increased mortality after measles infection: a community study from Guinea-Bissau. Pediatr Inf Dis J 1996;15:39-44.
21. Aaby P, Samb B, Andersen M, Simondon F. No long-term excess mortality after measles infection: A community study from Senegal. Am J Epidemiol 1996;143:1035-41.
22. Dollimore N, Cutts F, Binka, FN, Ross DA, Morris SS, Smith PG. Measles incidence, case fatality, and delayed mortality in children with and with vitamin A supplementation in rural Ghana. Am J Epidemiol 1997;146:646-54.
23. Demographic surveillance system-Matlab. Registration of Demographic Events. Scientific Reports no. 64, 67, 68, 69, 70, 71. Dhaka: International Centre for Diarrhoeal Disease Research, Bangladesh, 1985-1993.
24. Holt JD, Prentice RL. Survival analyses in twin studies and matched pair experiments. Biometrika 1974;61:17-30.
25. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-220.
26. de Francisco A, Fauveau V, Sarder AM, Chowdhury HR, Chakraborty J, Yunus MD. Measles in rural Bangladesh: Issues of validation and age distribution. Int J Epidemiol 1994;23:393-99.
27. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau. BMJ 2000;321:1435-38.
28. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles mortality, state of nutrition, and family structure: A community study from Guinea-Bissau. J Infect Dis 1983;147:693-701.
29. Schnorr JJ, Cutts FT, Wheeler JG et al. Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine 2001;19:1503-10.
30. Petralli JK, Merigan TC, Wilbur JR. Action of endogenous interferon against vaccinia infection in children. Lancet 1965;ii:401-05.
31. Pabst HF, Spady DW, Carson MM, Stelfox HT, Beeler JA, Krezolik MP. Kinetics of immunological responses after primary MMR vaccination. Vaccine 1997;15:10-14.
32. Ito M, Watanabe M, Karniya H, Sakurai M. Changes in intracellular levels in lymphocytes induced by measles virus. Clin Immunol Immunopathol 1997;83:281-86.
33. Fischer JE, Johnson JE, Johnson TR, Graham BS. Pertussis toxin sensitisation alters the pathogenesis of subsequent respiratory syncytial virus infection. J Inf Dis 2000;182:1029-38.
34. Graham BS, Henderson GS, Tang YW, Lu X, Neuzil KM, Colley DC. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993;151:2032-40.
35. Moran TM, Park H, Fernandez-Sesma A, Schulman JL. Th2 responses to inactivated influenza vaccine can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Inf Dis 1999;180:579-85.
36. Hall A, Aaby P. Tropical trials and tribulations. Int J Epidemiol 1990; 19:777-81.
37. Aaby P, Andersen M, Sodemann M, Jakobsen M, Gomes J, Fernandes M. Reduced childhood mortality following standard measles vaccination at 4-8 months compared to 9-11 months of age. BMJ 1993; 307:1308-11.